Literature DB >> 18481270

The role of steroid hormones in the NF1 phenotype: focus on pregnancy.

Therese M Roth1, Elizabeth M Petty, Kate F Barald.   

Abstract

The Neurofibromatosis Type 1 (NF1) gene functions as a tumor suppressor gene. Loss of its protein, neurofibromin, in the autosomal dominant disorder NF1 is associated with peripheral nervous system tumors, particularly neurofibromas, benign lesions in which the major cell type is the Schwann Cell (SC). Benign and malignant human tumors found in NF1 patients are heterogeneous with respect to their cellular composition. The number and size of neurofibromas in NF1 patients has been shown to increase during pregnancy, with, in some cases, post-partum regression, which suggests hormonal involvement in this increase. However, in this review, we consider evidence from the literature that both direct hormonal influence on tumor growth and on angiogenesis may contribute to these effects. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481270     DOI: 10.1002/ajmg.a.32301

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  18 in total

1.  The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 +/- or NF1 -/- genotype derived from human cutaneous neurofibromas.

Authors:  Paula Pennanen; Sirkku Peltonen; Roope A Kallionpää; Juha Peltonen
Journal:  Mol Cell Biochem       Date:  2017-11-28       Impact factor: 3.396

2.  Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells.

Authors:  Hua Li; Xuelian Zhang; Lauren Fishbein; Frederick Kweh; Martha Campbell-Thompson; George Q Perrin; David Muir; Margaret Wallace
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

3.  Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type I.

Authors:  Urania Dagalakis; Maya Lodish; Eva Dombi; Ninet Sinaii; Jessica Sabo; Andrea Baldwin; Seth M Steinberg; Constantine A Stratakis; Brigitte C Widemann
Journal:  J Pediatr       Date:  2013-12-08       Impact factor: 4.406

4.  Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis.

Authors:  Araika Gutiérrez-Rivera; Haizea Iribar; Anna Tuneu; Ander Izeta
Journal:  Stem Cells Int       Date:  2012-04-01       Impact factor: 5.443

5.  Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006).

Authors:  Maria Masocco; Yllka Kodra; Monica Vichi; Susanna Conti; Mark Kanieff; Monica Pace; Luisa Frova; Domenica Taruscio
Journal:  Orphanet J Rare Dis       Date:  2011-03-25       Impact factor: 4.123

6.  Gender dimorphism and age of onset in malignant peripheral nerve sheath tumor preclinical models and human patients.

Authors:  Elizabeth Shurell; Linh M Tran; Jonathan Nakashima; Kathleen B Smith; Brenna M Tam; Yunfeng Li; Sarah M Dry; Noah Federman; William D Tap; Hong Wu; Fritz C Eilber
Journal:  BMC Cancer       Date:  2014-11-15       Impact factor: 4.430

7.  Double NF1 inactivation affects adrenocortical function in NF1Prx1 mice and a human patient.

Authors:  Karolina Kobus; Daniela Hartl; Claus Eric Ott; Monika Osswald; Angela Huebner; Maja von der Hagen; Denise Emmerich; Jirko Kühnisch; Hans Morreau; Frederik J Hes; Victor F Mautner; Anja Harder; Sigrid Tinschert; Stefan Mundlos; Mateusz Kolanczyk
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

Review 8.  The NF1 gene revisited - from bench to bedside.

Authors:  Yoon-Sim Yap; John R McPherson; Choon-Kiat Ong; Steven G Rozen; Bin-Tean Teh; Ann S G Lee; David F Callen
Journal:  Oncotarget       Date:  2014-08-15

9.  Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.

Authors:  Yu-chi Shen; Ravi Upadhyayula; Stephanie Cevallos; Ryan J Messick; Tammy Hsia; Mathew P Leese; Douglas M Jewett; Daysha Ferrer-Torres; Therese M Roth; Wolfgang Dohle; Barry V L Potter; Kate F Barald
Journal:  Br J Cancer       Date:  2015-10-13       Impact factor: 7.640

10.  Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?

Authors:  Adila Alkindy; Nadia Chuzhanova; Usha Kini; David N Cooper; Meena Upadhyaya
Journal:  Hum Genomics       Date:  2012-08-13       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.